XIB4035, a novel nonpeptidyl small molecule agonist for GFRα-1

Neurochemistry International

Volumn 42, Issue 1, 2003, Pages 81-86

  Tokugawa, Kimiko ^a   Yamamoto, Kyoko ^a   Nishiguchi, Mariko ^a   Sekine, Takumi ^a   Sakai, Masahiko ^a   Ueki, Tomokazu ^a   Chaki, Shigeyuki ^a   Okuyama, Shigeru ^a  

^a TAISHO PHARMACEUTICAL CO LTD   (Japan)

Author keywords

GDNF; GFR 1; Nonpeptidyl small molecule agonist; XIB4035

Indexed keywords

DIAMINE DERIVATIVE; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR RECEPTOR ALPHA 1; GROWTH FACTOR RECEPTOR; N 4 [7 CHLORO 2 [2 (2 CHLOROPHENYL)VINYL]QUINOLIN 4 YL] N1,N1 DIETHYLPENTANE 1,4 DIAMINE; PROTEIN RET; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; AUTOPHOSPHORYLATION; CELL SURVIVAL; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOTOXICITY; DRUG ACTIVITY; IC 50; IMMUNOBLOTTING; MOUSE; NERVE FIBER GROWTH; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING;

ANIMALS; ANTIPARKINSON AGENTS; BINDING, COMPETITIVE; DEPRESSION, CHEMICAL; DROSOPHILA PROTEINS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR RECEPTORS; MICE; MOLECULAR STRUCTURE; NEOPLASM PROTEINS; NERVE GROWTH FACTORS; NEURITES; NEUROBLASTOMA; PHOSPHORYLATION; PROTEIN BINDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; QUINOLINES; RECEPTOR PROTEIN-TYROSINE KINASES; TUMOR CELLS, CULTURED;

EID: 0037210204     PISSN: 01970186     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-0186(02)00053-0     Document Type: Article

References (34)

1. Beck K.D., Valverde J., Alexi T., Poulsen K., Moffat B., Bandlen R.A., Rosenthal A., Hefti F. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature. 373:1995;339-341.
2. Bowenkamp K.E., Hoffman A.F., Gerhardt G.A., Henry M.A., Biddle P.T., Hoffer B.J., Granholm A.C. Glial cell line-derived neurotrophic factor supporrts survival of injured midbrain dopaminergic neurons. J. Comparative Neurol. 355:1995;479-489.
3. Durbec P.L., Larsson-Blomberg L.B., Schuchardt A., Constantini F., Pachnis V. Common origin and developmental dependence on c-Ret of subset of enteric and sympathetic neuroblasts. Development. 122:1996;349-358.
4. Durbec P., Marcos-Gutierrez C.V., Kilkenny C., Grigoriou M., Suvanto P., Wartiovaara K., Smith D., Ponder B., Costantini F., Saarma M., Sariola H., Pachnis V. Glial cell line-derived neurotrophic factor signaling through the Ret receptor tyrosine kinase. Nature. 381:1996;789-792.
5. Encinas M., Tansey M.C., Tsui-Pierchala B.A., Comella J.X., Milbrandt J., Johnson E.M. Jr. C-Src is required for glial cell line-derived neurotrophic factor (GDNF) family ligand-mediated neuronal survival via a phosphatidylinositol-3 kinase(PI-3K)-dependent pathway. J. Neurosci. 21:2001;1464-1472.
6. Gash D.M., Zhang Z., Ovadia A., Cass W.A., Yi A., Simmerman L., Russel D., Martin D., Lapchak P.A., Collins F., Hoffer B.J., Gerhardt G.A. Functional recovery in Parkinsonian monkeys treated with GDNF. Nature. 380:1996;252-255.
7. German D.C., Manaye K.F., Sonsalla P.K., Brooks B.A. Midbrain dopaminergic cell loss in Parkinson's disease and MPTP-induced Parkinsonism: sparing of calbindin-D28k-containing cells. Annu. N.Y. Acad. Sci. 648:1992;42-62.
8. Grondin R., Gash D.M. Grial cell line-derived neurotrophic factor (GDNF): a drug candidate for the treatment of Parkinson's diesease. J. Neurol. 245(Suppl.):1998;35-42.
9. Harlow, E., Lane, D., 1988. Antibodies: A Laboratory Manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, New York.
10. Henderson C.E., Phillips H.S., Pollock R.A., Davies A.M., Lemeulle C., Armanini M., Simpson L.C., Moffet B., Vandlen R.A., Koliatsos V.E., Rosenthal A. GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science. 266:1994;1062-1064.
11. Herbert M.A., Van Horne C.G., Hoffer B.J., Gerhardt G.A. Functional effects of GDNF in normal rat striatum: presynaptic studies using in vivo electrochemistry and microdialysis. J. Pharmacol. Exp. Ther. 279:1996;1181-1190.
12. Hoffer B., Hoffman A., Bowenkamp K., Huettl P., Hudson J., Martin D., Lin L., Gerhardt G. Glial cell line-derived neurotrophic factor reverses toxin-induced injury to midbrain dopaminergic neurons in vivo. Neurosci. Lett. 182:1994;107-111.
13. Hornykiewicz O., Kish S.J. Biochemical pathophysiology of Parkinson's disease. Adv. Neurol. 45:1987;19-34.
14. Horger B.A., Nishimura M.C., Armanini M.P., Wang L.C., Poulsen K.T., Rosenblad C., Kirik D., Moffat B., Simmons L., Johnson E. Jr., Milbrandt J., Rosenthal A., Bjorklund A., Vandlen R.A., Hynes M.A., Phillips H.S. Neurturin exerts potent actions on survival and function of midbrain dopaminergic neurons. J. Neurosci. 18:1998;4929-4937.
15. Hou J.G.G., Lin L.F.H., Mytilineou C. Glial cell line-derived neurotrophic factor exerts neurotrophic effects on dopaminergic neurons in vitro and promotes their survival and re-growth after damage by 1-methyl-4-phenylpyridinium. J. Neurochem. 66:1996;74-82.
16. Hudson J., Granholm A.-C., Gerhardt G.A., Henry M.A., Hoffman A., Biddle P., Leala N.S., Mackerlova L., Lile J.D., Collins F., Hofer B.J. Glial cell line-derived neurotrophic factor augments midbrain dopaminergic circuits in vivo. Brain Res. Bull. 36:1995;425-432.
17. Ikeda I., Ishizuka Y., Tahira T., Suzuki T., Onda M., Sugimura T., Nagao M. Specific expression of the Ret proto-oncogene in human neuroblastoma lines. Oncogene. 5:1990;1291-1296.
18. Jing S., Wen D., Yu Y., Holst P.L., Luo L., Fang M., Tamir R., Antonio L., Hu Z., Cupples R., Louis J.C., Hu S., Altrock B.W., Fox G.M. GDNF-induced activation of the Ret protein tyrosine kinase is mediated by GDNFR-α, a Novel Receptor for GDNF. Cell. 85:1996;1113-1124.
19. Jing S., Yu Y., Fang M., Hu Z., Holst P.L., Boone T., Delaney J., Schultz H., Zhou R., Fox G.M. GFRα-2 and GFRα-3 are two new receptors for ligands of the GDNF family. J. Biol. Chem. 272:1997;3311-3317.
20. Jone K.H., Senft J.A. An improved method to determine cell biability by simultaneous staining with fluorescein diacetate-propidium iodide. J. Histochem. Cytochem. 33:1985;77-79.
21. Klein R.D., Sherman D., Ho W., Stone D., Bennett G.L., Moffat B., Vandlen R., Simmons L., Gu Q., Hongo J., Devaux B., Poulsen K., Armanini M., Nozaki C., Asai N., Goddard A., Phillips H., Henderson C., Takahashi M., Rosenthal A. A GPI-linked protein that interacts with Ret to form a candidate neurturin receptor. Nature. 387:1997;717-721.
22. Lin L.F., Doherty D.H., Lile J.D., Bektesh S., Collins F. GDNF: a glial cell line-derived neurotrophic factor for midbrain dopaminergic neurons. Science. 260:1993;1130-1132.
23. Milbrandt J., de Sauvage F.J., Fahrner T.J., Baloh R.H., Leitner M.L., Tansey M.G., Lampe P.A., Heuckeroth R.O., Kotzbauer P.T., Simburger K.S., Golden J.P., Davies J.A., Vejsada R., Kato A.C., Hynes M., Sherman D., Nishimura M., Wang L.C., Vandlen R., Moffat B., Klein R.D., Poulesen K., Gray C., Garces A., Johnson E.M. Jr. Persephin, a novel neurotrophic factor related to GDNF and neurturin. Neuron. 20:1998;245-253.
24. Oppenheim R.W., Houenou L.J., Johnson J.E., Lin L.F.H., Li L., Lo A.C., Newsome A.L., Prevette D.M., Wang S. Developing motor neurons rescued from programmed and axotomy-induced cell death by GDNF. Nature. 373:1995;344-346.
25. Pong K., Xu R.Y., Beck K.D., Thang T.J., Louis J.C. Inhibition of glial cell line-derived neurotrophic factor induced intracellular activity by K-252b on dopaminergic neurons. J. Neurochem. 69:1997;986-994.
26. Sauer H., Rosenblad C., Bjorklund A. GDNF but not TGF-β3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine-lesion. Proc. Natl. Acad. Sci. U.S.A. 92:1995;8935-8939.
27. Skaper S.D., Kee W.J., Facci L., Macdonald G., Doherty P., Walsh F.S. The FGFR1 inhibitor PD 173074 selectively and potently antagonizes FGF-2 neurotrophic and neurotropic effects. J. Neurochem. 75:2000;1520-1527.
28. Thompson J., Doxakis E., Pinow G.P., Strachan P., Buj-Bello A., Wyatt S., Buchman V.L., Davies A.M. GFRα-4, a new GDNF family receptor. Mol. Cell Neurosci. 11:1998;117-126.
29. Tomac A., Lindqvist E., Lin L.F.H., Ogren S.O., Young D., Hoffer B.J., Olson L. Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo. Nature. 373:1995;335-339.
30. Treanor J.J.S., Goodman L., de Sauvage F., Stone D.M., Poulsen K.T., Beck K.D., Grany C., Armanini M.P., Pollock R.A., Hefti F., Phillips H.S., Goddard A., Moore M.W., Buj-Bello A., Davies A.M., Asai N., Takahashi M., Vandlen R., Henderson C.E., Rosenthal A. Characterization of a multicomponent receptor for GDNF. Nature. 382:1996;80-83.
31. Trupp M., Belluardo N., Funakoshi H., Ibanez C.F. Complementary and overlapping expression of glial cell line-derived neurotrophic factor (GDNF), c-Ret prot-oncogene and GDNF receptor-α indicates multiple mechanisms of trophic actions in adult rat CNS, c-Ret prot-oncogene and GDNF receptor-α indicates multiple mechanisms of trophic actions in adult rat CNS. J. Neurosci. 17:1997;3554-3567.
32. Ullrich A., Schlessinger J. Signal transduction by receptors with tyrosine kinase activity. Cell. 61:1990;203-212.
33. Yamamoto, K., Tokugawa, K., Nishiguchi, M., Chaki, S., Okuyama, S. Neuro-2A Cells As A Useful Model to Investigate Signaling Mechanisms and Functions Mediated Through GFRα-1, submitted for publications.
34. Yan Q., Matheson C., Lopez O.T. In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature. 373:1995;341-344.